Notice: Prescription Drug List (PDL): Triamcinolone acetonide

The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt Triamcinolone acetonide.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis : Liste des drogues sur ordonnance (LDO) : acétonide de triamcinolone
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2017-05-18 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["avis de modification", "Liste des drogues sur ordonnance", "LPD", "Acétonide de triamcinolone"], "en": ["notice of amendment", "Prescription Drug List", "PDL", "Triamcinolone acetonide"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source